European Archives - Page 128 of 1143 - European Medical Journal

High-Dose Vitamin C Extends Survival in Metastatic Pancreatic Cancer

Adding high-dose intravenous vitamin C to standard chemotherapy significantly improves survival in patients with metastatic pancreatic cancer.

Stronger Topical Steroids Show Greater Benefit for Moderate Atopic Dermatitis in Children

Potent corticosteroids provide superior symptom relief for moderate atopic dermatitis flare-ups in children, enhancing primary care management.

Innovative Video Game Test Detects Autism in Children in One Minute

A one-minute video game, CAMI, identifies autism with 80% accuracy, distinguishing it from ADHD and neurotypical development.

A New Novel Biomarker for Kidney Stones in Hyperparathyroidism

A high calcium-to-magnesium ratio predicts nephrolithiasis in primary hyperparathyroidism, offering enhanced diagnostic accuracy and specificity.

Breaking Barriers: Why COPD Diagnosis Is Often Delayed

A new qualitative study conducted in France highlights the multiple obstacles patients face before receiving a chronic obstructive pulmonary disease diagnosis.

Cannabis Use Linked to Reduced Brain Activity in Memory Tasks

Cannabis use Linked to reduced brain activity in memory tasks, recent studies using fMRI show.

Propranolol’s Surprising Role in Reducing Parkinson’s Tremor

New research shows propranolol reduces Parkinson’s tremor and motor cortex activity, offering a potential treatment option.

Key Metabolic Vulnerability in Multiple Myeloma Treatment

New research identifies VLCFA metabolism as a target to boost multiple myeloma treatment efficacy and combat drug resistance.

Study Confirms Type 2 Diabetes Raises Heart Risks in Atherosclerosis

A new study has confirmed that type 2 diabetes significantly increases the risk of major cardiovascular events, regardless of atherosclerosis severity.

COVAIL Trial Reveals Insights Into Antibody Levels and Vaccine Efficacy

New data from the COVAIL trial highlight the importance of neutralizing antibody titers in reducing COVID-19 risk after mRNA boosters, with stronger protection observed in individuals with prior SARS-CoV-2 infection.